AI Companies' Pivot to Biomedical Research Raises Commercial Concerns

AI companies are pivoting towards biomedical research, a move hailed as a boon for humanity but a bearish signal for their own commercial prospects. This shift highlights the intense competition and monetization challenges in the general AI sector, forcing companies to seek vertical applications.

2026-07-30 ~ 2026-07-30 · 2 related posts